Treatment of acute tacrolimus toxicity with phenytoin after Paxlovid (nirmatrelvir/ritonavir) administration in a kidney transplant recipient-Reference-Cited by-同舟云学术

Treatment of acute tacrolimus toxicity with phenytoin after Paxlovid (nirmatrelvir/ritonavir) administration in a kidney transplant recipient

Published:2022-11-30 Issue:6 Volume:41 Page:768-770
ISSN:2211-9140
Container-title:Kidney Research and Clinical Practice
language:en
Short-container-title:Kidney Res Clin Pract

Author:

Kwon Eun-Jeong^ORCID,Yun Gi-Ae^ORCID,Park Seokwoo^ORCID,Kim Sejoong^ORCID,Chae Dong-Wan^ORCID,Park Hyung Sub^ORCID,Lee Taeseung^ORCID,Jeong Jong Cheol^ORCID

Publisher

The Korean Society of Nephrology

Subject

Urology,Nephrology

Link

http://krcp-ksn.org/upload/pdf/j-krcp-22-218.pdf

Reference6 articles.

1. Therapeutic Monitoring of Calcineurin Inhibitors for the Nephrologist

2. Nirmatrelvir/ritonavir use: Managing clinically significant drug-drug interactions with transplant immunosuppressants

3. Early clinical experience with nirmatrelvir/ritonavir for the treatment of COVID-19 in solid organ transplant recipients

4. Effect of nirmatrelvir/ritonavir on calcineurin inhibitor levels: Early experience in four SARS-CoV-2 infected kidney transplant recipients

5. Two distinct cases with COVID‐19 in kidney transplant recipients

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of rifampicin administration on CYP induction in a dermatomyositis patient with vasospastic angina attributable to nilmatrelvir/ritonavir-induced blood tacrolimus elevation: A case report;Journal of Infection and Chemotherapy;2024-09

2. Case report and literature review: management of Paxlovid (nirmatrelvir/ritonavir)-induced acute tacrolimus toxicity in a patient with systemic lupus erythematosus;Frontiers in Pharmacology;2024-06-19

3. Prevention and treatment strategies for kidney transplant recipients in the context of long-term existence of COVID-19;Frontiers in Medicine;2024-04-03

4. Case report: Paralytic ileus resulted from nirmatrelvir/ritonavir-tacrolimus drug-drug interaction in a systemic lupus erythematosus patient with COVID-19;Frontiers in Pharmacology;2024-03-27

5. Phenytoin enzyme induction for management of supratherapeutic tacrolimus levels due to drug-drug interaction with nirmatrelvir/ritonavir: Case series and discussion;American Journal of Health-System Pharmacy;2024-02-13